PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25753330-0	2015	Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects.	Curcumin	6-14	epidermal growth factor receptor	Homo sapiens	35-39	
25753330-0	2015	Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects.	Curcumin	6-14	epidermal growth factor receptor	Homo sapiens	91-95	
25753330-1	2015	Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR.	Curcumin	0-8	epidermal growth factor receptor	Homo sapiens	73-105	
25753330-1	2015	Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR.	Curcumin	0-8	epidermal growth factor receptor	Homo sapiens	107-111	
25753330-1	2015	Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR.	Curcumin	0-8	epidermal growth factor receptor	Homo sapiens	173-177	
25753330-6	2015	Among all evaluated curcumin derivatives, compound 2 showed the best inhibitory effects on both wild-type and mutant EGFR by efficiently inducing gefitinib-insensitive EGFR degradation.	Curcumin	20-28	epidermal growth factor receptor	Homo sapiens	117-121